Former President Joe Biden has commenced a five-week course of radiation therapy, supplementing his ongoing hormone treatment for an aggressive form of prostate cancer. This latest phase in his healthcare journey addresses a diagnosis first revealed in May, which indicated the cancer had already spread to his bones, highlighting the complexities of managing such conditions, especially in older individuals.
The health of prominent public figures often draws significant attention, offering a window into medical advancements and the personal battles behind the headlines. Former U.S. President Joe Biden, who will turn 83 next month and was the oldest serving president in U.S. history, is currently undergoing radiation therapy for an aggressive form of prostate cancer. This treatment, which began a few weeks ago, is a crucial component of a broader plan that includes hormone therapy, addressing a diagnosis made public in May.
The Diagnosis and Treatment Plan
President Biden’s prostate cancer was diagnosed in May after he reported experiencing issues with his urinary system. Examinations revealed a small nodule on his prostate, which was subsequently determined to be an aggressive, hormone-sensitive form of cancer. A spokesperson confirmed that the cancer had metastasized to the bone when it was first announced. This spread, while making the cancer incurable, does not diminish the effectiveness of modern treatments in extending life expectancy and improving quality of life, as highlighted by experts like Dr. Benjamin Davies, a professor of urologic oncology at the University of Pittsburgh Medical Center.
The current treatment regimen combines two powerful approaches:
- Hormone Therapy: This initial line of defense targets the cancer’s hormone sensitivity by preventing testosterone from being produced or reaching the cancer cells. Testosterone often fuels prostate cancer growth, so blocking it can significantly slow progression.
- Radiation Therapy: Expected to span five weeks, radiation therapy is now being employed to further control the cancer. According to the American Cancer Society, radiation in advanced prostate cancer that has metastasized to the bones can help keep it under control for as long as possible and prevent or relieve symptoms.
When the diagnosis was first revealed, Biden himself expressed optimism, telling CNN that he expected to “beat this.” He noted that the cancer was “not in any organ” and that his “bones are strong,” indicating that it hadn’t deeply penetrated the bone structure. His Gleason score was reported as 9, which is indicative of a highly aggressive form of prostate cancer, yet modern advancements in treatment offer substantial hope for management.
A Broader Health Picture: Skin Cancer and Public Initiatives
Biden’s recent health updates extend beyond his prostate cancer. Just last month, in early September, he underwent a Mohs surgery to remove cancerous cells from his skin. This procedure is a common and effective treatment for various skin cancers, involving the removal of thin layers of skin until no cancer cells remain under microscopic examination. This was not his first encounter with skin cancer; in 2023, while still president, a lesion removed from his chest was confirmed to be basal cell carcinoma, the most common and typically curable type of skin cancer.
Beyond his personal health battles, President Biden has also been a vocal advocate for cancer research and treatment on a national scale. While in office, he launched the “Cancer Moonshot” program, an ambitious initiative aimed at accelerating progress in cancer prevention, diagnosis, and treatment. This program seeks to significantly reduce the cancer death rate and improve the experience of people living with cancer.
Prostate Cancer in Context: Age, Aggressiveness, and Outlook
Prostate issues, including cancer, are notably common among older men, a demographic that President Biden fits into. The aggressiveness of his cancer, indicated by its Gleason score of 9 and spread to the bones, signifies a serious condition. However, advancements in urologic oncology have transformed the landscape of treatment for metastatic prostate cancer. While a cure might not be possible once it has spread, newer hormonal and chemotherapy therapies have shown impressive results, significantly extending the longevity and quality of life for patients. Dr. Jamin Brahmbhatt, a urologist not involved in Biden’s care, emphasized that even with high-risk prostate cancer, patients can often “live a pretty normal life and have a good quality of life, as long as the cancer is treated.”
The public transparency regarding President Biden’s health provides valuable insight into the challenges and triumphs of modern cancer treatment. It underscores the importance of early detection and the continuous evolution of medical science in managing complex diseases, offering both a personal narrative and a broader educational opportunity for the community.
